Skip to content
Free shipping and returns
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
  • Log in
  • YouTube
  • LinkedIn
Cart
Subtotal
$0.00
Shipping, taxes, and discount codes calculated at checkout.
Your cart is currently empty.
Refundable Security Deposit for Sudoscan Refundable Security Deposit for Sudoscan Sudoscan Logo white Sudoscan Logo white
  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop
account Log in icon-bag-minimalCart
Access Denied
IMPORTANT! If you’re a store owner, please make sure you have Customer accounts enabled in your Store Admin, as you have customer based locks set up with EasyLockdown app. Enable Customer Accounts
Home / Media & Events / Successful Webinar “Management of autonomic dysfunction” – July 2021
Events · Feb 18, 2023

Successful Webinar “Management of autonomic dysfunction” – July 2021

Webinar Success message from July 2021 webinar

Webinar Success: Addressing Autonomic Dysfunction Management - Challenges and the Role of Sudomotor Testing

With our special guests, on July 2021;

On July the 16th Impeto Medical had organized a webinar for health professionals on the Management of autonomic dysfunction.

We were glad to welcome more than 50 attendees to this presentation with our special guests Pr Vincenza Spallone and Pr Peter Novak.

The autonomic system (sudomotors) regulates the activity of sweat glands. Sudomotor dysfunction is among the earliest neurophysiologic abnormalities observed in distal small fiber neuropathies. Quantitative measurement of sweat response has been proposed as a marker of the severity and distribution of autonomic failure and an early indicator of small fiber regeneration. Diabetes is the main cause of small fiber neuropathy, with sudomotor dysfunction being a significant clinical manifestation of diabetic autonomic neuropathy, according to the ADA. In addition, evaluating autonomic dysfunction can help identify patients at high risk for cardiac autonomic neuropathy, which has a high rate of morbidity and mortality.

In this webinar Pr Vincenza Spallone and Pr Peter Novak pointed out the challenges of the assessment of diabetic cardiovascular autonomic neuropathy (CAN) and the clinical utility of SUDOSCAN to improve patients management.

Pr Vincenza Spallone works at the Endocrinology Department of Systems Medicine, University Tor Vergata of Rome. She was Chairperson and invited Speaker at more than 35 International meetings (including EASD and Neurodiab). She is reviewer for 29 journals and more than 160 articles. She has also published about 374 works (articles, chapters, books, and abstracts).

Pr Peter Novak is Associate Professor of Neurology at Harvard Medical School. He is Director of Autonomic Laboratory at Brigham and Women’s Faulkner Hospital, Boston. His main interests are small fibers and autonomic neuropathies and has over 70 papers written & presented at numerous conferences.

Share Share on Facebook Share Tweet on X Pin it Pin on Pinterest

icon-left-arrow Back to Media & Events
Invalid password
Enter
Sudoscan Logo

SUDOSCAN® is a privately-owned French medical device company.

Created in June 2005, SUDOSCAN is located in San Diego, CA, USA; the company's corporate headquarters are in Paris, France. We service all of the North and South America, The Middle East, Europe and Asia.

  • YouTube
  • LinkedIn

Sudoscan

  • About SUDOSCAN®
  • Our Company
  • Medical Articles
  • Approved Cleaning Products
  • Media & Events
  • Contact Us
  • SUDOSCAN® Shop

Shop SUDOSCAN

  • Login
  • Create account
  • SUDOSCAN® Shop

Resources

  • For Physicians
  • Reimbursement Regulatory
  • Approved Cleaning Products
  • For Patients
  • SUDOSCAN® Videos
  • SUDOSCAN® Image Gallery
  • SUDOSCAN® Articles

CONTACT INFO:

US TERRITORIES:
SUDOSCAN Inc.
8525 Gibbs Dr. Suite 304
San Diego, CA 92123

Phone: +1 858 450 2800

INTERNATIONAL:
Impeto Medical
2 Rue Maurice Hartmann,
92130 Issy-les-Moulineaux,
France

Phone: +33 (0)7 87 20 32 03
Website: www.sudoscan.com

Promotional Communication. The medical devices SUDOSCAN® is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 05/10/2023

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Visa
© 2025 SUDOSCAN USA | Autonomic & Sudomotor Testing Device Powered by Shopify
Successful Webinar on Autonomic Dysfunction - July 2021